4-57031325-C-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The ENST00000295666.6(IGFBP7):c.841G>A(p.Glu281Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000203 in 1,602,136 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
ENST00000295666.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
IGFBP7 | NM_001553.3 | c.841G>A | p.Glu281Lys | missense_variant | 5/5 | ENST00000295666.6 | NP_001544.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
IGFBP7 | ENST00000295666.6 | c.841G>A | p.Glu281Lys | missense_variant | 5/5 | 1 | NM_001553.3 | ENSP00000295666 | P2 | |
IGFBP7 | ENST00000512512.3 | n.481G>A | non_coding_transcript_exon_variant | 5/5 | 5 |
Frequencies
GnomAD3 genomes AF: 0.000146 AC: 22AN: 150774Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000303 AC: 75AN: 247700Hom.: 0 AF XY: 0.000306 AC XY: 41AN XY: 134152
GnomAD4 exome AF: 0.000209 AC: 303AN: 1451246Hom.: 2 Cov.: 28 AF XY: 0.000228 AC XY: 165AN XY: 722532
GnomAD4 genome AF: 0.000146 AC: 22AN: 150890Hom.: 0 Cov.: 32 AF XY: 0.000150 AC XY: 11AN XY: 73566
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 12, 2021 | The c.841G>A (p.E281K) alteration is located in exon 5 (coding exon 5) of the IGFBP7 gene. This alteration results from a G to A substitution at nucleotide position 841, causing the glutamic acid (E) at amino acid position 281 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at